The Global Orthostatic Hypotension Market Size gathered USD 715.2 Million in 2021 and is set to garner a market size of USD 1,422.9 Million by 2030 growing at a CAGR of 8.1% from 2022 to 2030.
Orthostatic hypotension, also identified as postural hypotension, occurs when a person's blood pressure drops considerably when they stand up from a sitting or lying down position. This can result in dizziness, fainting, and lightheadedness. The trouble with the body's capacity to regulate blood pressure in response to changes in posture causes orthostatic hypotension. When a person stands up, their body automatically constricts the blood vessels and increases the heart rate to prevent blood from pooling in their legs. This process fails in people with orthostatic hypotension, resulting in a drop in blood pressure and reduced blood flow to the brain. Orthostatic hypotension is a relatively common condition, and the number of cases may be increasing for several reasons. Some of the leading aspects for the prevalence of orthostatic hypotension include the increasing aging population and growing occurrences of chronic disorders.
Orthostatic Hypotension Market Report Statistics
- Global orthostatic hypotension market revenue is estimated to reach USD 1,422.9 Million by 2030 with a CAGR of 8.1% from 2022 to 2030
- North America orthostatic hypotension market value gathered more than USD 293 million in 2021
- Asia-Pacific orthostatic hypotension market growth will record a CAGR of more than 8.6% from 2022 to 2030
- Among end-use, hospitals and clinics sub-segment collected revenue of around US$ 322 million in 2021
- The growing number of research & development activities is a popular orthostatic hypotension market trend that drives the industry demand
Global Orthostatic Hypotension Market Dynamics
Market Drivers
- Increasing aging population
- Growing incidences of chronic disorders
- Rising demand for diagnostic tests
Market Restraints
- Lack of clinical evidence
- Side effects of the drugs
Market Opportunities
- Advancement in technology
- Increasing trend of combination therapy in O.H. treatment
Orthostatic Hypotension Market Report Coverage
| Market |
Orthostatic Hypotension Market |
| Orthostatic Hypotension Market Size 2021 |
USD 715.2 Million |
| Orthostatic Hypotension Market Forecast 2030 |
USD 1,422.9 Million |
| Orthostatic Hypotension Market CAGR During 2022 - 2030 |
8.1% |
| Orthostatic Hypotension Market Analysis Period |
2018 - 2030 |
| Orthostatic Hypotension Market Base Year |
2021 |
| Orthostatic Hypotension Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Drug Type, By Diagnostics Test Type, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Amgen, Amneal Pharmaceuticals LLC, Apotex, Inc., Chelsea Therapeutics, F. Hoffman-La Roche, H. Lundbeck A/S, Mylan Inc, Novartis AG, Pfizer Inc., and Upsher-Smith Laboratories.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Orthostatic Hypotension Market Growth Factors
The growing elderly population is one of the primary drivers that are fueling the orthostatic hypotension market value. As people get older, their chances of developing orthostatic hypotension and other age-related health problems rise, creating a greater need for treatment options. Another driver is the high rate of chronic conditions such as diabetes and heart disease, which can cause nerve damage that makes it difficult for the body to regulate blood pressure, growing the risk of developing orthostatic hypotension and thus the need for treatments. Another factor that is driving the orthostatic hypotension drugs market includes the increasing use of medications that can cause orthostatic hypotension as a side effect. The growing number of people taking these medications is leading to more cases of orthostatic hypotension, and increasing demand for effective treatment options.
However, market growth may be limited due to a lack of awareness and diagnosis of the condition, as well as a lack of effective treatment options. It is critical to raise general public and healthcare professional education and awareness about the condition and its symptoms in order to improve diagnosis, recovery, and follow-up care. Furthermore, the global orthostatic hypotension market is set to grow at a rapid pace during the forecast period, owing to an increase in the geriatric population and a rise in the incidence of chronic diseases such as diabetes.
Orthostatic Hypotension Market Segmentation
The worldwide orthostatic hypotension market is categorized based on drug type, diagnostics test type, end-use, and geography.
Orthostatic Hypotension Market By Drug Type
- Caffeine
- Droxidopa
- Epoetin
- Fludrocortisone
- Indomethacin
- Midodrine hydrochloride
- NSAIDs ( Nonsteroidal anti-inflammatory drugs)
- Oxilofrine potassium chloride
- Pyridostigmine
According to our orthostatic hypotension industry analysis, the midodrine hydrochloride sub-segment will have a significant market share in 2021. Midodrine is a common example of a sympathomimetic drug used to treat orthostatic hypotension. Midodrine raises blood pressure and improves blood flow to the brain by constricting blood vessels. Droxidopa, ephedrine, and norepinephrine are some other sympathomimetics used to treat orthostatic hypotension. Fludrocortisone, a mineralocorticoid, is another type of drug used to treat orthostatic hypotension. Fludrocortisone works by increasing the body's salt and water retention, which raises blood pressure and improves blood flow to the brain.
Orthostatic Hypotension Market By Diagnostics Test Type
- Blood Tests
- ECG
- Echocardiogram
- Stress Test
Based on diagnostic test type, the blood tests sub-segment is expected to account for a notable market share between 2022 and 2030. A variety of diagnostic tests can be used to diagnose orthostatic hypotension. The orthostatic vital signs test, also identified as the "postural blood pressure test" or "tilt table test," is the most commonly used test. A person's blood pressure and heart rate are measured while lying down and again while standing up during the test. The test is typically performed in a medical office or clinic and takes 10 to 15 minutes. Within 3 minutes of standing, the test measures a drop in systolic blood pressure of at least 20 mm Hg or a drop in diastolic blood pressure of at least 10 mm Hg.
Orthostatic Hypotension Market By End-Use Type
- Ambulatory Surgical Centers
- Hospitals and Clinics
- Diagnostic Centers
According to the orthostatic hypotension market forecast, the hospital and clinics sub-segment is expected to witness a significant growth rate between 2022 and 2030. The presence of numerous healthcare specialists, the facility of quick treatment options, and the existence of emergency units are some of the factors that are supporting the hospital segment in the orthostatic hypotension market. Furthermore, the rapid growth in multi-specialist hospitals and increasing investment in building advanced healthcare infrastructure are also some key factors that will boost segment growth in the forthcoming period.
Orthostatic Hypotension Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Orthostatic Hypotension Market Regional Analysis
In 2021, North America region is held for the dominant share in the global orthostatic hypotension market owing to the high prevalence of chronic conditions such as diabetes the large number of aging population in the region. In addition, the region's high healthcare expenditure and presence of well-established healthcare infrastructure are contributing to the market's growth in North America.
The Asia-Pacific market is expected to grow at a significant rate during the forecast period, owing to an ageing population and an increase in the prevalence of chronic conditions such as diabetes, obesity, and heart disease. Furthermore, rising healthcare expenditures and growing awareness of orthostatic hypotension in the region are expected to drive market growth in Asia-Pacific.
Orthostatic Hypotension Market Players
Some of the leading orthostatic hypotension companies include Amgen, Amneal Pharmaceuticals LLC, Apotex, Inc., Chelsea Therapeutics, F. Hoffman-La Roche, H. Lundbeck A/S, Mylan Inc, Novartis AG, Pfizer Inc., and Upsher-Smith Laboratories.
CHAPTER 1. Industry Overview of Orthostatic Hypotension Market
1.1. Definition and Scope
1.1.1. Definition of Orthostatic Hypotension
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Orthostatic Hypotension Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Orthostatic Hypotension Market By Drug Type
1.2.3. Orthostatic Hypotension Market By Diagnostics Test Type
1.2.4. Orthostatic Hypotension Market By End-Use
1.2.5. Orthostatic Hypotension Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Orthostatic Hypotension Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Orthostatic Hypotension Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Orthostatic Hypotension Market By Drug Type
5.1. Introduction
5.2. Orthostatic Hypotension Market Revenue By Drug Type
5.2.1. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast, By Drug Type, 2018-2030
5.2.2. Caffeine
5.2.2.1. Caffeine Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Droxidopa
5.2.3.1. Droxidopa Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Epoetin
5.2.4.1. Epoetin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Fludrocortisone
5.2.5.1. Fludrocortisone Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Indomethacin
5.2.6.1. Indomethacin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Midodrine Hydrochloride
5.2.7.1. Midodrine Hydrochloride Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.8. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
5.2.8.1. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.9. Oxilofrine Potassium Chloride
5.2.9.1. Oxilofrine Potassium Chloride Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.10. Pyridostigmine
5.2.10.1. Pyridostigmine Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Orthostatic Hypotension Market By Diagnostics Test Type
6.1. Introduction
6.2. Orthostatic Hypotension Market Revenue By Diagnostics Test Type
6.2.1. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast, By Diagnostics Test Type, 2018-2030
6.2.2. Blood Tests
6.2.2.1. Blood Tests Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. ECG
6.2.3.1. ECG Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Echocardiogram
6.2.4.1. Echocardiogram Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Stress Test
6.2.5.1. Stress Test Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Orthostatic Hypotension Market By End-Use
7.1. Introduction
7.2. Orthostatic Hypotension Market Revenue By End-Use
7.2.1. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
7.2.2. Ambulatory Surgical Centers
7.2.2.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Clinics
7.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Diagnostic Centers
7.2.4.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.5. Hospitals
7.2.5.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Orthostatic Hypotension Market By Country
8.1. North America Orthostatic Hypotension Market Overview
8.2. U.S.
8.2.1. U.S. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.2.2. U.S. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
8.2.3. U.S. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Canada
8.3.1. Canada Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
8.3.2. Canada Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
8.3.3. Canada Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Orthostatic Hypotension Market By Country
9.1. Europe Orthostatic Hypotension Market Overview
9.2. U.K.
9.2.1. U.K. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.2.2. U.K. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
9.2.3. U.K. Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Germany
9.3.1. Germany Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.3.2. Germany Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
9.3.3. Germany Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. France
9.4.1. France Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.4.2. France Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
9.4.3. France Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Spain
9.5.1. Spain Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.5.2. Spain Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
9.5.3. Spain Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
9.6.2. Rest of Europe Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
9.6.3. Rest of Europe Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia-Pacific Orthostatic Hypotension Market By Country
10.1. Asia-Pacific Orthostatic Hypotension Market Overview
10.2. China
10.2.1. China Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.2.2. China Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.2.3. China Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Japan
10.3.1. Japan Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.3.2. Japan Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.3.3. Japan Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. India
10.4.1. India Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.4.2. India Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.4.3. India Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Australia
10.5.1. Australia Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.5.2. Australia Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.5.3. Australia Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6. South Korea
10.6.1. South Korea Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.6.2. South Korea Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.6.3. South Korea Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
10.7.2. Rest of Asia-Pacific Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
10.7.3. Rest of Asia-Pacific Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.8. Asia-Pacific PEST Analysis
CHAPTER 11. Latin America Orthostatic Hypotension Market By Country
11.1. Latin America Orthostatic Hypotension Market Overview
11.2. Brazil
11.2.1. Brazil Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.2.2. Brazil Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
11.2.3. Brazil Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Mexico
11.3.1. Mexico Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.3.2. Mexico Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
11.3.3. Mexico Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
11.4.2. Rest of Latin America Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
11.4.3. Rest of Latin America Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Orthostatic Hypotension Market By Country
12.1. Middle East & Africa Orthostatic Hypotension Market Overview
12.2. GCC
12.2.1. GCC Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
12.2.2. GCC Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
12.2.3. GCC Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. South Africa
12.3.1. South Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
12.3.2. South Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
12.3.3. South Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Drug Type, 2018-2030
12.4.2. Rest of Middle East & Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By Diagnostics Test Type, 2018-2030
12.4.3. Rest of Middle East & Africa Orthostatic Hypotension Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Orthostatic Hypotension Market
13.1. Orthostatic Hypotension Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Orthostatic Hypotension Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Amgen
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2021
14.1.3.2. Amgen 2021 Orthostatic Hypotension Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Amneal Pharmaceuticals LLC
14.3. Apotex, Inc.
14.4. Chelsea Therapeutics
14.5. F. Hoffman-La Roche
14.6. H. Lundbeck A/S
14.7. Mylan Inc
14.8. Novartis AG
14.9. Pfizer Inc.
14.10. Upsher-Smith Laboratories
